BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11723166)

  • 1. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
    Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
    J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
    Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
    J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
    Dunlop J; Beal McIlvain H; She Y; Howland DS
    J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
    Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
    Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1.
    Warita H; Manabe Y; Murakami T; Shiote M; Shiro Y; Hayashi T; Nagano I; Shoji M; Abe K
    Neurol Res; 2002 Sep; 24(6):577-81. PubMed ID: 12238624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the glutamate transporter variants GLT-1a and GLT-1b in the cortex and spinal cord of transgenic rats expressing hSOD1(G93A).
    Dumont AO; Hermans E; Goursaud S
    Neurochem Int; 2013 Aug; 63(2):61-8. PubMed ID: 23665075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
    Vermeiren C; Hemptinne I; Vanhoutte N; Tilleux S; Maloteaux JM; Hermans E
    J Neurochem; 2006 Feb; 96(3):719-31. PubMed ID: 16371010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
    J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress.
    Tortarolo M; Crossthwaite AJ; Conforti L; Spencer JP; Williams RJ; Bendotti C; Rattray M
    J Neurochem; 2004 Jan; 88(2):481-93. PubMed ID: 14690536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
    Albano R; Liu X; Lobner D
    Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS.
    Yin HZ; Tang DT; Weiss JH
    Exp Neurol; 2007 Oct; 207(2):177-85. PubMed ID: 17719032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice.
    Guo Y; Duan W; Li Z; Huang J; Yin Y; Zhang K; Wang Q; Zhang Z; Li C
    FEBS Lett; 2010 Apr; 584(8):1615-22. PubMed ID: 20303959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.
    Wilson JM; Khabazian I; Pow DV; Craig UK; Shaw CA
    Neuromolecular Med; 2003; 3(2):105-18. PubMed ID: 12728193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.